EMPOWER

What this means for you

Not registered yet, but its 03 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99026675

Mark type

Design + words

Filed

03 Feb 2025

Attorney of record

John A. Yates

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular, lymphatic, respiratory, pulmonary, neurological, renal, gastrointestinal, musculoskeletal, dermatological, allergic, inflammatory, autoimmune, gynecological, genetic, longevity, metabolic, and pain conditions; Pharmaceutical preparations for weight management, hormone replacement therapy, intravenous therapy, intravenous nutrition therapy, intravenous hydration therapy, injectable nutrition, dietary nutrition, injectable amino acids, injectable minerals, injectable vitamins, mental health, skin care, sexual dysfunction, fertility, men's sexual health, women's reproductive health, and gender-affirming care; Sanitizing wipes; Disinfecting wipes; Antiseptic wipes
• Class 010 — Medical apparatus: Medical syringes; Containers especially adapted for the disposal of medical instruments and syringes; Trocars
• Class 035 — Advertising and business services: Retail pharmacy services; Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Supply chain management services
• Class 040 — Treatment of materials: Contract manufacturing in the field of pharmacology, microbiology, toxicology, and biotechnology.; Biomanufacturing services for others in the field of pharmaceuticals; Custom manufacturing of biological preparations, chemical preparation, and reagents for others; Custom manufacturing of chemicals and ingredients for pharmaceuticals for research and scientific purposes for others; Custom manufacturing of pharmaceuticals; Custom manufacturing of biopharmaceutical and biotechnological products for others
• Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical products development; Consulting services in the field of pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Providing scientific research information in the field of pharmaceuticals; Research and development services of new pharmaceutical products; Research and development services in the field of medical preparations; Scientific research in the nature of conducting clinical trials for others; Packaging design for others; Providing quality assurance services in the field of pharmaceuticals; Computer technology support services, namely, help desk services; Research laboratory analysis services in the field of pharmaceuticals; Laboratory research in the field of pharmaceuticals; Laboratory testing of materials; Research laboratory analysis services in the field of pharmacology, microbiology, toxicology, and biotechnology; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of pharmacology, microbiology, toxicology, and biotechnology; Testing, analysis, and evaluation of pharmaceuticals to assure compliance with industry standards
• Class 044 — Medical, beauty and agricultural services: Pharmaceutical compounding services; Medical and pharmaceutical consultation; Preparation of prescriptions by pharmacists
• Class 045 — Legal and security services: Regulatory compliance consulting in the field of pharmaceuticals

Owner

• Empower Clinic Services, L.L.C., Houston, TX, US

Prosecution history

• 12 Feb 2026 — ASSIGNED TO EXAMINER
• 23 Jan 2026 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
• 23 Jan 2026 — TEAS VOLUNTARY AMENDMENT RECEIVED
• 14 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 14 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 14 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 13 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 13 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 14 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 14 Jul 2025 — NON-FINAL ACTION E-MAILED
• 14 Jul 2025 — NON-FINAL ACTION WRITTEN
• 14 Jul 2025 — ASSIGNED TO EXAMINER
• 03 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 03 Feb 2025 — APPLICATION FILING RECEIPT MAILED
• 03 Feb 2025 — NEW APPLICATION ENTERED